BSE filing, BSE: 544482. Summary written from the filing by ALFA Finder's alert engine.
Star Imaging and Path Lab Ltd: key numbers
- Share price
- ₹74.10
- Market cap
- ₹129.1 Cr
- Revenue (annual)
- ₹88.53 Cr
- Net profit (annual)
- ₹19.28 Cr
- P/E (TTM)
- 6.7×Sector 51.1×
- Promoter holding
- 71.92%
- FII holding
- 0.06%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Star Imaging and Path Lab Ltd
All →Star Imaging and Path Lab Business Update
Star Imaging and Path Lab has been empanelled with the Municipal Corporation of Delhi to provide diagnostic services at CGHS rates.
- From
- Municipal Corporation of Delhi (MCD)
Star Imaging and Path Lab Annual General Meeting
Star Imaging and Path Lab Limited held its 22nd Annual General Meeting on September 29, 2026, where shareholders considered financial statements and director re-appointments.
Star Imaging and Path Lab Production Started
Star Imaging and Path Lab has commenced commercial operations of a new CT scan diagnostic facility at R G Stone Hospital in Faridabad, Haryana.
Star Imaging and Path Lab Annual General Meeting
Star Imaging and Path Lab Limited has scheduled its 22nd Annual General Meeting for September 29, 2026. The meeting will be conducted via video conferencing.
Star Imaging and Path Lab Annual Report
Star Imaging and Path Lab Limited has released its Annual Report for FY 2025-26. The 22nd AGM is scheduled for September 29, 2026, via video conferencing.
Star Imaging and Path Lab Board Meeting Outcome
The company announced the outcome of its board meeting, including approval of the draft notice for the 22nd AGM and various audit and appointment matters.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.